187 related articles for article (PubMed ID: 21423621)
21. The human papillomavirus E7 oncoprotein and the cellular transcription factor E2F bind to separate sites on the retinoblastoma tumor suppressor protein.
Wu EW; Clemens KE; Heck DV; Münger K
J Virol; 1993 Apr; 67(4):2402-7. PubMed ID: 8445736
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of aldose reductase prevents growth factor-induced G1-S phase transition through the AKT/phosphoinositide 3-kinase/E2F-1 pathway in human colon cancer cells.
Ramana KV; Tammali R; Srivastava SK
Mol Cancer Ther; 2010 Apr; 9(4):813-24. PubMed ID: 20354121
[TBL] [Abstract][Full Text] [Related]
23. Role of the retinoblastoma (pRb)-E2F/DP pathway in cancer chemopreventive effects of green tea polyphenol epigallocatechin-3-gallate.
Ahmad N; Adhami VM; Gupta S; Cheng P; Mukhtar H
Arch Biochem Biophys; 2002 Feb; 398(1):125-31. PubMed ID: 11811957
[TBL] [Abstract][Full Text] [Related]
24. Protein domains governing interactions between E2F, the retinoblastoma gene product, and human papillomavirus type 16 E7 protein.
Huang PS; Patrick DR; Edwards G; Goodhart PJ; Huber HE; Miles L; Garsky VM; Oliff A; Heimbrook DC
Mol Cell Biol; 1993 Feb; 13(2):953-60. PubMed ID: 7678696
[TBL] [Abstract][Full Text] [Related]
25. Reversible repression of papillomavirus oncogene expression in cervical carcinoma cells: consequences for the phenotype and E6-p53 and E7-pRB interactions.
von Knebel Doeberitz M; Rittmüller C; Aengeneyndt F; Jansen-Dürr P; Spitkovsky D
J Virol; 1994 May; 68(5):2811-21. PubMed ID: 8151752
[TBL] [Abstract][Full Text] [Related]
26. Mutagenesis of the pRB pocket reveals that cell cycle arrest functions are separable from binding to viral oncoproteins.
Dick FA; Sailhamer E; Dyson NJ
Mol Cell Biol; 2000 May; 20(10):3715-27. PubMed ID: 10779361
[TBL] [Abstract][Full Text] [Related]
27. Human papillomavirus type 16 E7 binds to E2F1 and activates E2F1-driven transcription in a retinoblastoma protein-independent manner.
Hwang SG; Lee D; Kim J; Seo T; Choe J
J Biol Chem; 2002 Jan; 277(4):2923-30. PubMed ID: 11713253
[TBL] [Abstract][Full Text] [Related]
28. Identification of a novel retinoblastoma gene product binding site on human papillomavirus type 16 E7 protein.
Patrick DR; Oliff A; Heimbrook DC
J Biol Chem; 1994 Mar; 269(9):6842-50. PubMed ID: 8120046
[TBL] [Abstract][Full Text] [Related]
29. Cancerous inhibitor of protein phosphatase 2A contributes to human papillomavirus oncoprotein E7-induced cell proliferation via E2F1.
Zhang W; Chen H; Chen Y; Liu J; Wang X; Yu X; Chen JJ; Zhao W
Oncotarget; 2015 Mar; 6(7):5253-62. PubMed ID: 25650660
[TBL] [Abstract][Full Text] [Related]
30. Two cytodifferentiation agent-induced pathways, differentiation and apoptosis, are distinguished by the expression of human papillomavirus 16 E7 in human bladder carcinoma cells.
Richon VM; Russo P; Venta-Perez G; Cordon-Cardo C; Rifkind RA; Marks PA
Cancer Res; 1997 Jul; 57(13):2789-98. PubMed ID: 9205091
[TBL] [Abstract][Full Text] [Related]
31. The growth arrest and downregulation of c-myc transcription induced by ceramide are related events dependent on p21 induction, Rb underphosphorylation and E2F sequestering.
Alesse E; Zazzeroni F; Angelucci A; Giannini G; Di Marcotullio L; Gulino A
Cell Death Differ; 1998 May; 5(5):381-9. PubMed ID: 10200487
[TBL] [Abstract][Full Text] [Related]
32. The relative ability of human papillomavirus type 6 and human papillomavirus type 16 E7 proteins to transactivate E2F-responsive elements is promoter- and cell-dependent.
Armstrong DJ; Roman A
Virology; 1997 Dec; 239(1):238-46. PubMed ID: 9426463
[TBL] [Abstract][Full Text] [Related]
33. Human papillomavirus type 16 E7 maintains elevated levels of the cdc25A tyrosine phosphatase during deregulation of cell cycle arrest.
Nguyen DX; Westbrook TF; McCance DJ
J Virol; 2002 Jan; 76(2):619-32. PubMed ID: 11752153
[TBL] [Abstract][Full Text] [Related]
34. Differential anticancer activities of arsenic trioxide on head and neck cancer cells with different human papillomavirus status.
Du S; Liu K; Gao P; Li Z; Zheng J
Life Sci; 2018 Nov; 212():182-193. PubMed ID: 30243648
[TBL] [Abstract][Full Text] [Related]
35. Destabilization of the retinoblastoma tumor suppressor by human papillomavirus type 16 E7 is not sufficient to overcome cell cycle arrest in human keratinocytes.
Helt AM; Galloway DA
J Virol; 2001 Aug; 75(15):6737-47. PubMed ID: 11435552
[TBL] [Abstract][Full Text] [Related]
36. The human papillomavirus E7 oncoprotein.
McLaughlin-Drubin ME; Münger K
Virology; 2009 Feb; 384(2):335-44. PubMed ID: 19007963
[TBL] [Abstract][Full Text] [Related]
37. Activation of the retinoblastoma tumor suppressor mediates cell cycle inhibition and cell death in specific cervical cancer cell lines.
Bourgo RJ; Braden WA; Wells SI; Knudsen ES
Mol Carcinog; 2009 Jan; 48(1):45-55. PubMed ID: 18506774
[TBL] [Abstract][Full Text] [Related]
38. Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways.
Goodwin EC; DiMaio D
Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12513-8. PubMed ID: 11070078
[TBL] [Abstract][Full Text] [Related]
39. Expression of cyclin E renders cyclin D-CDK4 dispensable for inactivation of the retinoblastoma tumor suppressor protein, activation of E2F, and G1-S phase progression.
Keenan SM; Lents NH; Baldassare JJ
J Biol Chem; 2004 Feb; 279(7):5387-96. PubMed ID: 14645251
[TBL] [Abstract][Full Text] [Related]
40. TGFbeta-mediated formation of pRb-E2F complexes in human myeloid leukemia cells.
Hu XT
Biochem Biophys Res Commun; 2008 May; 369(2):277-80. PubMed ID: 18294958
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
